Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CORPAY, INC.FLT · Entity 3172 | CEO UK & Austarlia/New Zealand | March 01, 2018 | March 08, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CORPAY, INC.
Report date March 01, 2018 · Filed March 08, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $199.75 · Expires 2028-03-01 | Direct | 15,000 |
Reported balance
After 2018-03-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-03-01 · Grant · Acquired 15,000 · Balance 15,000 F1: Options vest 0% in 2018 and 2019 and then ratably (50%) on each of December 31, 2020 and 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: Options vest 0% in 2018 and 2019 and then ratably (50%) on each of December 31, 2020 and 2021.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2018 Filed Mar 8, 2018 13:25 UTC | CORPAY, INC. FLT · Entity 3172 | GrantStock Options · Derivative | 15,000 | $0.00 Strike: $199.75 | $0.00 |
DisclosureSEC source: 0001209191-18-017894 · doc4.xml · derivative · entry 1 Maxsimic David D · CIK 0001317496 · CEO UK & Austarlia/New Zealand 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2028-03-01 F1 · security: Options vest 0% in 2018 and 2019 and then ratably (50%) on each of December 31, 2020 and 2021. Read SEC document |
| May 05, 2017 Filed May 10, 2017 01:01 UTC | CORPAY, INC. FLT · Entity 3172 | GrantStock Options · Derivative | 30,000 | $0.00 Strike: $133.40 | $0.00 |
DisclosureSEC source: 0001209191-17-031134 · doc4.xml · derivative · entry 1 Maxsimic David D · CIK 0001317496 · CEO UK & Austarlia/New Zealand 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2027-05-05 F1 · security: Options vest ratably (50%) on each of May 5, 2018 and 2019. Read SEC document |
| February 23, 2017 Filed Feb 25, 2017 00:07 UTC | CORPAY, INC. FLT · Entity 3172 | SaleCommon Stock | 2,000 | $166.13 | $332,256.00 |
DisclosureSEC source: 0001209191-17-014540 · doc4.xml · nonDerivative · entry 2 Maxsimic David D · CIK 0001317496 · CEO UK & Austarlia/New Zealand 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Pursuant to 10b5-1 Sales Plan Read SEC document |
| February 22, 2017 Filed Feb 25, 2017 00:07 UTC | CORPAY, INC. FLT · Entity 3172 | SaleCommon Stock | 1,125 | $165.67 | $186,384.04 |
DisclosureSEC source: 0001209191-17-014540 · doc4.xml · nonDerivative · entry 1 Maxsimic David D · CIK 0001317496 · CEO UK & Austarlia/New Zealand 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 F1 · security: Pursuant to 10b5-1 Sales Plan Read SEC document |
| February 17, 2017 Filed Feb 22, 2017 01:23 UTC | CORPAY, INC. FLT · Entity 3172 | SaleCommon Stock | 900 | $166.15 | $149,535.00 |
DisclosureSEC source: 0001209191-17-012992 · doc4.xml · nonDerivative · entry 3 Maxsimic David D · CIK 0001317496 · CEO UK & Austarlia/New Zealand 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,125 F2 · security: Pursuant to 10b5-1 Sales Plan Read SEC document |
| February 16, 2017 Filed Feb 22, 2017 01:23 UTC | CORPAY, INC. FLT · Entity 3172 | SaleCommon Stock | 560 | $167.60 | $93,855.89 |
DisclosureSEC source: 0001209191-17-012992 · doc4.xml · nonDerivative · entry 2 Maxsimic David D · CIK 0001317496 · CEO UK & Austarlia/New Zealand 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,025 F2 · security: Pursuant to 10b5-1 Sales Plan Read SEC document |
| February 16, 2017 Filed Feb 22, 2017 01:23 UTC | CORPAY, INC. FLT · Entity 3172 | GrantCommon Stock | 3,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-012992 · doc4.xml · nonDerivative · entry 1 Maxsimic David D · CIK 0001317496 · CEO UK & Austarlia/New Zealand 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,585 F1 · security: Vesting of performance based restricted stock Read SEC document |
| February 09, 2017 Filed Feb 13, 2017 23:13 UTC | CORPAY, INC. FLT · Entity 3172 | GrantCommon Stock | 1,460 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-010161 · doc4.xml · nonDerivative · entry 1 Maxsimic David D · CIK 0001317496 · CEO UK & Austarlia/New Zealand 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,460 F1 · security: Vesting of performance based restricted stock Read SEC document |
| January 23, 2017 Filed Jan 24, 2017 23:43 UTC | CORPAY, INC. FLT · Entity 3172 | SaleCommon Stock | 1,270 | $150.11 | $190,639.70 |
DisclosureSEC source: 0001209191-17-005400 · doc4.xml · nonDerivative · entry 1 Maxsimic David D · CIK 0001317496 · CEO UK & Austarlia/New Zealand 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Pursuant to 10b5-1 sales plan Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.